Crowcon Detection Instruments appoints global sales director
Graham Franklin gains promotion at gas detection specialist
Franklin has held a number of senior positions at the Abingdon, Oxfordshire, UK based firm. He was most recently sales director for Europe and has also been service manager, USA sales manager and UK sales manager.
Crowcon is a subsidiary of Halma, a leading supplier of portable and fixed gas detection instruments.
You may also like
Manufacturing
Why CAPA keeps failing and what strong organisations do differently
This white paper examines why CAPA systems often close records without preventing recurrence, tracing breakdowns to investigation quality, risk reasoning, and organisational behaviour rather than procedural gaps. It outlines what differentiates compliant CAPA programmes from those that consistently reduce repeat findings and inspection risk
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Beyond FAT and SAT: a practical framework to qualify multivendor pharmaceutical manufacturing lines (part II)
How a centralised qualification matrix reconciles vendor documentation, integrates risk-based verification and connects commissioning findings with deviation, CAPA and audit-ready evidence
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Regulatory
Beyond FAT and SAT: a practical framework to qualify multivendor pharmaceutical manufacturing lines (part I)
Documentation Specialist Snehal Godse explains why unit-level FAT and SAT leave critical multivendor interfaces unverified and proposes a risk-based framework to qualify product transfers, control signals, interlocks, sensors and shared utilities
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Research grade to GMP: how peptide quality requirements change as development progresses
This article presents a practical guide to matching peptide characterisation, impurity control, traceability and manufacturing oversight with rising regulatory expectations across preclinical and clinical development